These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18670278)

  • 1. Gene therapy in bladder cancer.
    Bochner BH
    Curr Opin Urol; 2008 Sep; 18(5):519-23. PubMed ID: 18670278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for superficial bladder cancer.
    Rosser CJ; Benedict WF; Dinney CP
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):531-9. PubMed ID: 12113085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospects.
    Miyake H; Hara I; Fujisaw M; Gleave ME
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):1001-9. PubMed ID: 16336091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of bladder cancer: targets for diagnosis and therapy.
    Baffa R; Letko J; McClung C; LeNoir J; Vecchione A; Gomella LG
    J Exp Clin Cancer Res; 2006 Jun; 25(2):145-60. PubMed ID: 16918124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy in thyroid cancer.
    Spitzweg C
    Horm Metab Res; 2009 Jun; 41(6):500-9. PubMed ID: 19434562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targeting and gene delivery in bladder cancer therapy.
    Voutsinas GE; Stravopodis DJ
    J BUON; 2009 Sep; 14 Suppl 1():S69-78. PubMed ID: 19785072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccination and gene therapy: optimization and delivery for cancer therapy.
    Bodles-Brakhop AM; Draghia-Akli R
    Expert Rev Vaccines; 2008 Sep; 7(7):1085-101. PubMed ID: 18767956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in ocular gene therapy.
    Chung DC; Lee V; Maguire AM
    Curr Opin Ophthalmol; 2009 Sep; 20(5):377-81. PubMed ID: 19667988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for in vivo bone formation: recent advances.
    Lattanzi W; Pola E; Pecorini G; Logroscino CA; Robbins PD
    Eur Rev Med Pharmacol Sci; 2005; 9(3):167-74. PubMed ID: 16080636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways.
    Wallerand H; Reiter RR; Ravaud A
    Curr Opin Urol; 2008 Sep; 18(5):524-32. PubMed ID: 18670279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to improve drug delivery in bladder cancer therapy.
    Wirth M; Plattner VE; Gabor F
    Expert Opin Drug Deliv; 2009 Jul; 6(7):727-44. PubMed ID: 19538035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy of cancer: induction of anti-tumor immunity.
    Qian C; Prieto J
    Cell Mol Immunol; 2004 Apr; 1(2):105-11. PubMed ID: 16212896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of double targeting gene therapy by suicide gene combined with endostatin gene in treatment of bladder cancer: an experimental study].
    Pan JG; Zhou X; Han RF
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2700-4. PubMed ID: 19080691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
    Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
    Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal development of bladder cancer and its relevance to the clinical potential of HLA antigen and TP53 based gene therapy.
    Nouri AM; Oliver RT; Nardgund VH
    Cancer Surv; 1998; 31():109-28. PubMed ID: 15281320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.
    Morille M; Passirani C; Vonarbourg A; Clavreul A; Benoit JP
    Biomaterials; 2008; 29(24-25):3477-96. PubMed ID: 18499247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted gene-delivery strategies for angiostatic cancer treatment.
    Brandwijk RJ; Griffioen AW; Thijssen VL
    Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects and problems of gene therapy: an update.
    Górecki DC
    Expert Opin Emerg Drugs; 2001 Oct; 6(2):187-98. PubMed ID: 15989520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy of cancer in the clinic: good news in sight from Asia?
    Favaro E; Indraccolo S
    Curr Opin Mol Ther; 2007 Oct; 9(5):477-82. PubMed ID: 17932811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.